Intellectual Property India Publishes Patent Application for 'Inhibitors Of Solute Carrier Family 6A Member 19 (SLC6A19) And Methods Of Use Thereof' Filed by Maze Therapeutics, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044348 A) filed by Maze Therapeutics, Inc., San Francisco, on May 7, for 'inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereof.'

Inventor(s) include Pitzen, Jennifer; Macias, Maximiliano De La Higuera; Cooper, Nicole; Sinz, Christopher Joseph; Lee, Patrick Sang Tae; Wahlers, Jessica; Fastman, Nathan; Tzitzilonis, Christos; Morgans, Jr. David John; Liu, Yuxi; Reid, Adam Neil; Ziebenhaus, Chris; Schammel, Alexander Wayne; Karmel, Caleb Henry; and Mellem, Kevin.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, R2, R3, R5, R6, R7, R8, R9, R10, R11a, R12b, and X are as defined elsewhere herein. Also provided herein are methods of preparing compounds of formula (II). Also provided herein are methods of inhibiting SLC6A19 and methods of treating a SLC6A19- mediated disease, disorder, or condition in an individual in need thereof."

The patent application was internationally filed on Oct. 11, 2023, under International application No.PCT/US2023/076625.

Disclaimer: Curated by HT Syndication.